Operating Margin: 34.92%
Is the operating margin high or low?
The operating margin of 34.92% is 18% above its 5-year average of 29.65%, near the high end of its 5-year range (23.66%–34.97%).
As of Friday, June 26, 2026. 2.67% above its 12-month average of 34.01%.
RMD Operating Margin
Reported quarterly operating margin; no daily interpolation.
RMD Average Operating Margin Chart
RMD Current vs Average Operating Margin Chart
RMD Operating Margin Metrics
OPERATING MARGIN
34.92%
OPERATING MARGIN AVG TTM
34.01%
OPERATING MARGIN AVG 3Y
30.62%
OPERATING MARGIN AVG 5Y
29.65%
OPERATING MARGIN AVG 10Y
26.79%
OPERATING MARGIN AVG 15Y
25.89%
OPERATING MARGIN AVG 20Y
24.64%
CURRENT VS TTM AVG
+2.67%
CURRENT VS 3Y AVG
+14.05%
CURRENT VS 5Y AVG
+17.78%
CURRENT VS 10Y AVG
+30.34%
CURRENT VS 15Y AVG
+34.89%
CURRENT VS 20Y AVG
+41.73%
RMD Competitors' Operating Margin
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ResMed Inc. (RMD) | $28.93B | 34.92% | 34.01% | 30.62% | 29.65% |
| Veeva Systems Inc. (VEEV)vs › | $27.84B | 28.79% | 26.93% | 23.33% | 24.40% |
| DexCom, Inc. (DXCM)vs › | $26.76B | 21.45% | 17.22% | 16.09% | 15.13% |
| Biogen Inc. (BIIB)vs › | $31.39B | 15.65% | 22.44% | 23.65% | 25.70% |
| Moderna, Inc. (MRNA)vs › | $26.35B | -153.35% | -140.72% | -73.36% | -52.24% |
| IQVIA Holdings Inc. (IQV)vs › | $31.80B | 13.86% | 14.15% | 13.50% | 11.74% |
| Zoetis Inc. (ZTS)vs › | $32.07B | 37.57% | 37.33% | 36.70% | 36.14% |
| Mettler-Toledo International Inc. (MTD)vs › | $25.44B | 28.00% | 28.45% | 28.53% | 27.71% |
| Centene Corp. (CNC)vs › | $32.45B | -3.68% | -0.98% | 0.21% | 0.84% |
| Medline Inc. (MDLN)vs › | $32.87B | 7.04% | 8.25% | 6.70% | 6.70% |
Operating Efficiency
Gross Margin
61.7%
Operating Margin
34.9%
Operating Margin Formula & Definition
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Operating Margin FAQ
- What is the operating margin for ResMed Inc. (RMD)?
- The operating margin for RMD stock is 34.92%.
- Is ResMed Inc.'s operating margin high or low?
- The operating margin of 34.92% is 18% above its 5-year average of 29.65%, near the high end of its 5-year range (23.66%–34.97%).
- What is the TTM average operating margin for ResMed Inc. (RMD)?
- The TTM average operating margin for RMD stock is 34.01%.
- What is the 3Y average operating margin for ResMed Inc. (RMD)?
- The 3Y average operating margin for RMD stock is 30.62%.
- What is the 5Y average operating margin for ResMed Inc. (RMD)?
- The 5Y average operating margin for RMD stock is 29.65%.
- What is the 10Y average operating margin for ResMed Inc. (RMD)?
- The 10Y average operating margin for RMD stock is 26.79%.
- What is the 15Y average operating margin for ResMed Inc. (RMD)?
- The 15Y average operating margin for RMD stock is 25.89%.
- What is the 20Y average operating margin for ResMed Inc. (RMD)?
- The 20Y average operating margin for RMD stock is 24.64%.
RMD Operating Margin History
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | 34.92% |
| 2025-12-31 | 34.97% |
| 2025-09-30 | 33.43% |
| 2025-06-30 | 33.72% |
| 2025-03-31 | 33.00% |
| 2024-12-31 | 32.54% |
| 2024-09-30 | 31.63% |
| 2024-06-30 | 31.17% |
| 2024-03-31 | 31.29% |
| 2023-12-31 | 23.66% |
| 2023-09-30 | 26.22% |
| 2023-06-30 | 24.53% |
| 2023-03-31 | 26.92% |
| 2022-12-31 | 27.10% |
| 2022-09-30 | 29.02% |
| 2022-06-30 | 27.92% |
| 2022-03-31 | 27.10% |
| 2021-12-31 | 27.79% |
| 2021-09-30 | 28.97% |
| 2021-06-30 | 27.58% |
| 2021-03-31 | 29.06% |
| 2020-12-31 | 27.71% |
| 2020-09-30 | 28.84% |
| 2020-06-30 | 28.98% |
| 2020-03-31 | 28.27% |
| 2019-12-31 | 26.87% |
| 2019-09-30 | 25.12% |
| 2019-06-30 | 17.17% |
| 2019-03-31 | 23.70% |
| 2018-12-31 | 24.13% |
| 2018-09-30 | 24.50% |
| 2018-06-30 | 23.55% |
| 2018-03-31 | 23.05% |
| 2017-12-31 | 24.28% |
| 2017-09-30 | 21.49% |
| 2017-06-30 | 22.88% |
| 2017-03-31 | 20.89% |
| 2016-12-31 | 18.27% |
| 2016-09-30 | 20.23% |
| 2016-06-30 | 22.87% |
| 2016-03-31 | 22.98% |
| 2015-12-31 | 23.76% |
| 2015-09-30 | 23.81% |
| 2015-06-30 | 21.97% |
| 2015-03-31 | 25.06% |
| 2014-12-31 | 25.81% |
| 2014-09-30 | 24.89% |
| 2014-06-30 | 23.72% |
| 2014-03-31 | 26.32% |
| 2013-12-31 | 27.32% |
| 2013-09-30 | 27.09% |
| 2013-06-30 | 26.76% |
| 2013-03-31 | 25.05% |
| 2012-12-31 | 24.45% |
| 2012-09-30 | 23.69% |
| 2012-06-30 | 24.13% |
| 2012-03-31 | 21.93% |
| 2011-12-31 | 20.21% |
| 2011-09-30 | 19.34% |
| 2011-06-30 | 19.51% |
| 2011-03-31 | 63.92% |
| 2010-12-31 | 22.84% |
| 2010-09-30 | 23.54% |
| 2010-06-30 | 23.53% |
| 2010-03-31 | 21.95% |
| 2009-12-31 | 21.05% |
| 2009-09-30 | 21.32% |
| 2009-06-30 | 22.98% |
| 2009-03-31 | 23.05% |
| 2008-12-31 | 19.43% |
| 2008-09-30 | 16.78% |
| 2008-06-30 | 15.73% |
| 2008-03-31 | 17.65% |
| 2007-12-31 | 18.17% |
| 2007-09-30 | 17.10% |
| 2007-06-30 | 18.84% |
| 2007-03-31 | -11.96% |
| 2006-12-31 | 22.81% |
| 2006-09-30 | 21.59% |
| 2006-06-30 | 22.06% |
| 2006-03-31 | 22.64% |
| 2005-12-31 | 22.04% |
| 2005-09-30 | 19.28% |
| 2005-06-30 | 18.94% |
| 2005-03-31 | 24.92% |
| 2004-12-31 | 24.65% |
| 2004-09-30 | 23.89% |
| 2004-06-30 | 26.40% |
| 2004-03-31 | 24.64% |
| 2003-12-31 | 23.57% |
| 2003-09-30 | 26.01% |
| 2003-06-30 | 22.99% |
| 2003-03-31 | 24.79% |
| 2002-12-31 | 24.62% |
| 2002-09-30 | 26.48% |
| 2002-06-30 | -160.65% |
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell